Patrick A Flume MD
Critical Care Medicine, Pleural Disease
Professor, Medicine, Medical University of South Carolina College of Medicine
Join to View Full Profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Dr. Flume is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 1990 - 1993
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1987 - 1990- The University of Texas Health Science Center at San AntonioClass of 1987
Certifications & Licensure
SC State Medical License 1993 - 2027
NC State Medical License 1990 - 1998
TX State Medical License 1988 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation Start of enrollment: 2009 Sep 01
- MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis Start of enrollment: 2010 Nov 04
- Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients
- Join now to see all
Publications & Presentations
PubMed
- A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with...Michael W Konstan, James J Tolle, Emily DiMango, Patrick A Flume, Helen Usansky
Clinical Pharmacokinetics. 2025-08-03 - PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report.Sylvia Szentpetery, Dara Riva, Yair J Blumenfeld, John F Engelhardt, Carmen Luna-Paredes
Journal of Cystic Fibrosis. 2025-08-02 - Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis.Natalie E West, Michael W Konstan, Patrick A Flume, Donald R VanDevanter, Amalia Magaret
Journal of Cystic Fibrosis. 2025-07-01
Press Mentions
Over $26M in Funding Awarded to Charleston Health Research InstituteJune 11th, 2025- Bringing the Benefits of Clinical Research Within Reach for All South Carolina CommunitiesMay 29th, 2025
- New Breakthrough Treatments for Cystic FibrosisJuly 30th, 2024
- Join now to see all
Grant Support
- The South Carolina Clinical & Translational Research Institute (SCTR)MEDICAL UNIVERSITY OF SOUTH CAROLINA2025–2032
- South Carolina Clinical & Translational Research Institute (SCTR)MEDICAL UNIVERSITY OF SOUTH CAROLINA2015–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
